Reuters logo
BRIEF-Zoetis to acquire Nexvet for US$6.72 in Cash Per Share
April 13, 2017 / 2:28 PM / in 8 months

BRIEF-Zoetis to acquire Nexvet for US$6.72 in Cash Per Share

April 13 (Reuters) - Zoetis Inc

* Zoetis to acquire Nexvet Biopharma, an innovator in monoclonal antibody therapies for companion animals

* Deal for purchase price of US$6.72 per share

* Deal for approximately US$85 million in aggregate

* Board of directors of Nexvet has unanimously approved acquisition

* Under terms of proposed acquisition, Nexvet shareholders will receive us$6.72 in cash per ordinary share

* Cash consideration payable by Zoetis under terms of proposed acquisition will be funded by cash on hand Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below